drugset / Trial / NCT06385795

A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause

NCT06385795 ↗

Phase 2 Completed 40 enrolled Noema Pharma AG
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.

Timeline

Start
2024-04-22
Primary completion
2025-08-13
Completion
2025-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject NOE-115 Unknown — —

Indications

No indication recorded.